Â鶹ӳ»­

Researchers at Â鶹ӳ»­ MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor immune microenvironment (TIME) and significantly improved anti-tumor responses in preclinical models of pancreatic cancer.

In this study, published today in Nature Cancer, researchers used comprehensive immune...